Literature DB >> 16400722

FDA notifications. FDA approves new Kaletra formulation.

.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16400722

Source DB:  PubMed          Journal:  AIDS Alert        ISSN： 0887-0292


× No keyword cloud information.
  2 in total

1.  Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients.

Authors:  Leonardo Calza; Laura Mosca; Daria Pocaterra; Benedetta Piergentili; Vincenzo Colangeli; Roberto Manfredi; Annalisa Erario; Gabriele Grossi; Gabriella Verucchi; Pierluigi Viale
Journal:  Eur J Clin Pharmacol       Date:  2010-09-28       Impact factor: 2.953

2.  Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.

Authors:  Valeria Micheli; Mario Regazzi; Laura Dickinson; Paola Meraviglia; Paola Villani; Saye H Khoo; Paolo Viganò; Laura Cordier; Maria Cusato; Piergiorgio Duca; Giovanna Orlando; Giuliano Rizzardini; David J Back; Antonietta Cargnel
Journal:  Ther Drug Monit       Date:  2008-06       Impact factor: 3.681
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.